YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

Through its ownership stake in and license agreement with Genevant, Arbutus is also focused on maximizing opportunity for its ...

New research from the Perelman School of Medicine at the University of Pennsylvania suggests that a combination of messenger ...

The Trump administration has started quietly re-hiring some of the FDA employees that it fired last week in a process that ...

Generation Bio is a biotechnology company changing what's possible for people living with T cell-driven autoimmune diseases. The company is developing a new modality of therapeutics leveraging its T ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.